D
KalVista Pharmaceuticals, Inc. KALV
$13.31 $0.100.76% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2025 01/31/2025 10/31/2024 07/31/2024 04/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -16.78% -4.48% 10.42% 14.84% 7.34%
Gross Profit 16.78% 4.48% -10.42% -14.84% -7.34%
SG&A Expenses 114.24% 158.33% 129.72% 92.53% 77.41%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 33.86% 46.64% 46.05% 36.88% 26.67%
Operating Income -33.86% -46.64% -46.05% -36.88% -26.67%
Income Before Tax -42.17% -58.47% -55.49% -48.95% -36.31%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -44.85% -62.39% -55.49% -48.95% -36.31%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -44.85% -62.39% -55.49% -48.95% -36.31%
EBIT -33.86% -46.64% -46.05% -36.88% -26.67%
EBITDA -33.97% -46.85% -46.28% -37.05% -26.76%
EPS Basic -8.55% -18.75% -19.16% -11.87% -0.99%
Normalized Basic EPS -6.42% -15.97% -19.23% -12.81% -2.25%
EPS Diluted -8.55% -18.75% -19.16% -11.87% -0.99%
Normalized Diluted EPS -6.42% -15.97% -19.23% -12.81% -2.25%
Average Basic Shares Outstanding 34.84% 37.02% 30.12% 30.82% 31.78%
Average Diluted Shares Outstanding 34.84% 37.02% 30.12% 30.82% 31.78%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --